Back to Search
Start Over
PHASE I/II STUDY OF UMBRALISIB (TGR-1202) IN COMBINATION WITH UBLITUXIMAB (TG-1101) AND PEMBROLIZUMAB IN PATIENTS WITH REL/REF CLL AND RICHTER'S TRANSFORMATION
- Source :
- Hematological Oncology. 37:119-120
- Publication Year :
- 2019
- Publisher :
- Wiley, 2019.
Details
- ISSN :
- 02780232
- Volume :
- 37
- Database :
- OpenAIRE
- Journal :
- Hematological Oncology
- Accession number :
- edsair.doi...........9d335c86d6b975c1eae086e5d1feb78b